Skip to main content

Table 3 Comparison between CKD stages III IV, and V on HD laboratory findings and blood pressure assessment

From: Fatigue assessment and its predictors in pediatric patients with chronic kidney disease stages III to V

 

CKD III–IV (n=41)

CKD V (n= 73)

P value

Hemoglobin (gm/dl)

10.88 ± 1.7

10.70 ± 1.3

0.524

Total leucocyte count

7.83 ± 2.5

7.58 ± 2.5

0.614

Platelets (median (range))

217 (92–589)

213 (23–589)

0.032*

pH

7.38 ± 0.2

7.29 ± 1.1

0.522

HCO3 (median (range))

19 (15–23)

19 (15–79)

0.129

Base excess (median (range))

−6.4 (−11.5: −1.4)

−6 (−11.5: 7.4)

0.035*

Sodium

136.39 ± 4.6

119.99 ± 35.6

0.004*

Potassium

4.23 ± 1.1

5.69 ± 1.7

<0.001*

Calcium (median (range))

10.3 (8.6–12.7)

9.8 (7.2–42)

0.219

Phosphorous

5.19 ± 1.5

5.38 ± 1.9

0.578

ALP (median (range))

289 (94–804)

228 (7–859)

0.412

Albumin (median (range))

4.2 (3–5)

4.2 (3–18)

0.289

Blood pressurea

 Normo-/hypotensive

38 (92.7%)

30 (41.1%)

 

 Hypertensive

3 (7.3%)

43 (58.9%)

< 0.001*

SBP (mmHg)

104.2 ±10.8

121.5 ± 16.2

< 0.001*

DBP (mmHg)

67.3 ± 6.8

77.3 ± 11.6

< 0.001*

Serum creatinine

1.78 ± 0.8

7.37 ± 1.8

< 0.001*

  1. CKD chronic kidney disease, HD hemodialysis, ALP alkaline phosphatase, SBP systolic blood pressure, DBP diastolic blood pressure
  2. *Significant p value < 0.05
  3. aCount (percent). CKD V patients had significantly lowered platelet counts, serum sodium levels, and higher serum potassium and creatinine levels than CKD III-IV patients. Also, hypertension is significantly correlated to CKD V patients